# Clinical Trial Evaluating Safety and Efficacy of Resomelagon on Dengue Infection (RESOVIR-2)

> **NCT06917001** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Federal University of Minas Gerais** · enrollment: 120 (estimated)

## Conditions studied

- Dengue Fever

## Interventions

- **DRUG:** Resomelagon
- **DRUG:** Placebo
- **OTHER:** Standard Treatment

## Key facts

- **NCT ID:** NCT06917001
- **Lead sponsor:** Federal University of Minas Gerais
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2027-06
- **Final completion:** 2027-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-08-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06917001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06917001, "Clinical Trial Evaluating Safety and Efficacy of Resomelagon on Dengue Infection (RESOVIR-2)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06917001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*